{"title":"严重肺动脉高压（≥ 50mmhg）患者二尖瓣置换术的术后效果","authors":"Mourad Abdelbaki, Benalikhoudja H., Boudiaf Eh","doi":"10.23958/ijirms/vol09-i01/1805","DOIUrl":null,"url":null,"abstract":"Mitral valve replacement after mitral stenosis is directly related to rheumatic fever, which is very common in our country. The development of PAH is the most frequent evolutionary course of MR. This is a retrospective study of 55 patients with severe PAH. The aim of our study is to demonstrate that severe pulmonary hypertension is not a contraindication to mitral valve replacement, and that long-term results are good.","PeriodicalId":14008,"journal":{"name":"International Journal of Innovative Research in Medical Science","volume":" 39","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Postoperative Results of Mitral Valve Replacement in Patients with Severe Pulmonary Arterial Hypertension (≥ 50mmhg)\",\"authors\":\"Mourad Abdelbaki, Benalikhoudja H., Boudiaf Eh\",\"doi\":\"10.23958/ijirms/vol09-i01/1805\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Mitral valve replacement after mitral stenosis is directly related to rheumatic fever, which is very common in our country. The development of PAH is the most frequent evolutionary course of MR. This is a retrospective study of 55 patients with severe PAH. The aim of our study is to demonstrate that severe pulmonary hypertension is not a contraindication to mitral valve replacement, and that long-term results are good.\",\"PeriodicalId\":14008,\"journal\":{\"name\":\"International Journal of Innovative Research in Medical Science\",\"volume\":\" 39\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Innovative Research in Medical Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23958/ijirms/vol09-i01/1805\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Innovative Research in Medical Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23958/ijirms/vol09-i01/1805","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Postoperative Results of Mitral Valve Replacement in Patients with Severe Pulmonary Arterial Hypertension (≥ 50mmhg)
Mitral valve replacement after mitral stenosis is directly related to rheumatic fever, which is very common in our country. The development of PAH is the most frequent evolutionary course of MR. This is a retrospective study of 55 patients with severe PAH. The aim of our study is to demonstrate that severe pulmonary hypertension is not a contraindication to mitral valve replacement, and that long-term results are good.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
